Daniel Newman Mendelson, Director at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 3,000 shares at $6.25 ($19K) on 2024-01-09, disclosed to the SEC on 2024-01-10.
Open-market purchase of $19k CSBR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| CSBR | BUY | 2024-01-11 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-09 | $6K | — | Filing → |
| CSBR | BUY | 2024-01-08 | $18K | — | Filing → |